RxDoctor Payments Data

Eric Jackson, MD

Critical Care Medicine · North Rlington, NJNPI 1235131251

Payments from drug & device makers

$1,480in general payments, 2019–2025

Across 101 payments — averaging $14.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$335
  • GSK$250
  • AstraZeneca$208
  • Merck$136
  • Abbott$82
  • Lilly USA, LLC$72
  • plus $397 from 12 others

What the payments were for

  • Food & beverage$1,46899%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,480 in reported general payments places this provider in the 65th percentile of 254 critical care medicine providers in New Jersey.

See all critical care medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$58,164
Medicare patients
173
Services billed
764

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban49$41,469
OzempicSemaglutide21$24,096
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$18,230
MounjaroTirzepatide17$17,784
EntrestoSacubitril/Valsartan22$14,168
ShingrixVaricella-Zoster Ge/As01b/Pf56$11,553
AbrysvoRsv Vacc, Pref A And Pref B/Pf32$9,614
Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid16$3,534
Olmesartan Medoxomil77$2,502
Rosuvastatin Calcium167$2,223
Atorvastatin Calcium140$1,641
Albuterol Sulfate HfaAlbuterol Sulfate39$1,499
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide33$1,394
Carbamazepine11$1,020
Metformin Hcl110$1,008

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$58$51,08381 claims
GSKTrelegy Ellipta, Shingrix$250$29,78375 claims
Novo NordiskOzempic$335$24,09621 claims
Lilly USA, LLCMounjaro$72$17,78417 claims
NovartisEntresto$14$14,16822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 254 critical care medicine providers in New Jersey.

Other critical care medicine in North Rlington

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →